Trial NCT05079360

View at ClinicalTrials.gov 
Org. Study IDs: V2011201

Last trial update was posted on 2023-03-24

MeSH Interventions

Estrogen Receptor Modulators Estrogens Everolimus Exemestane Selective Estrogen Receptor Modulators

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

Decided to halt and will potentially reopen in the future.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID